Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Clinical trial NCT06392906 · RECRUITING

Trial details

NCT number: NCT06392906
Sponsor: Janjira Petsuksiri
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Associated Ophthalmopathy

Start date: 2024-07-11
Primary completion: 2028-04-30
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.